Literature DB >> 21111803

The modified HET-CAM as a model for the assessment of the inflammatory response to tissue tolerable plasma.

Claudia Bender1, Lars-Ivo Partecke, Eckhard Kindel, Friederike Döring, Jürgen Lademann, Claus-Dieter Heidecke, Axel Kramer, Nils-Olaf Hübner.   

Abstract

Plasma medicine is a novel, highly interdisciplinary field of research. Although the knowledge is rare concerning plasma based biomedical mechanisms, correct dosages and treatment times, animal experiments have been carried out. To follow the 3Rs (reduction, refinement, replacement), it is necessary to define methods for the screening of plasma parameters. In order to determine a reliable test and validate the use of tissue tolerable plasma (TTP) for the treatment of chronic wounds, we have selected the modified hen's egg test on the chorioallantoic membrane (mod. HET-CAM) as a model to benchmark the inflammation potential of plasma. Inflammations of different intensities provoked by using an HF-plasma jet corresponded to the time of plasma-tissue interaction. Additionally, the plasma mode and the gas composition were changed to assess their influence on the efficacy of treatment. Pulsed plasma led to the mildest inflammation, while the addition of 0.1% oxygen to the argon carrier gas led to the most distinct reaction. It was found that the influence of the exposure time was greater than that of the mode and the gas composition. All inflammations were alleviated, when hydrocortisone (HC) was added immediately after plasma treatment. The results of the study demonstrate that the modified HET-CAM test is suitable for screening plasma sources and for the determination of the optimum parameters for treatment of chronic wounds. To transfer the chronic wound into an acute healing wound without harmful inflammation, the maximum time for plasma-tissue interaction should not exceed 5s with the tested plasma source. Furthermore, it is possible to induce defined plasma-inflammations on the chorioallantoic membrane and to determine the anti-inflammatory potential of test substances.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21111803     DOI: 10.1016/j.tiv.2010.11.012

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  9 in total

1.  On the history of plasma treatment and comparison of microbiostatic efficacy of a historical high-frequency plasma device with two modern devices.

Authors:  Judith Napp; Georg Daeschlein; Matthias Napp; Sebastian von Podewils; Denis Gümbel; Romy Spitzmueller; Paolo Fornaciari; Peter Hinz; Michael Jünger
Journal:  GMS Hyg Infect Control       Date:  2015-06-02

2.  Efficacy of Tissue Tolerable Plasma (TTP) against Ixodes ricinus.

Authors:  Claudia Bender; Axel Kramer
Journal:  GMS Hyg Infect Control       Date:  2014-03-07

3.  Investigating the Mutagenicity of a Cold Argon-Plasma Jet in an HET-MN Model.

Authors:  Susanne Kluge; Sander Bekeschus; Claudia Bender; Hicham Benkhai; Axel Sckell; Harald Below; Matthias B Stope; Axel Kramer
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

4.  Side effects by oral application of atmospheric pressure plasma on the mucosa in mice.

Authors:  Lukasz Jablonowski; Thomas Kocher; Axel Schindler; Karolina Müller; Frank Dombrowski; Thomas von Woedtke; Thomas Arnold; Antje Lehmann; Stefan Rupf; Matthias Evert; Katja Evert
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 5.  3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model.

Authors:  Eric Pion; Julia Karnosky; Sofie Boscheck; Benedikt J Wagner; Katharina M Schmidt; Stefan M Brunner; Hans J Schlitt; Thiha Aung; Christina Hackl; Silke Haerteis
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

6.  Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo.

Authors:  Lars Ivo Partecke; Katja Evert; Jan Haugk; Friderike Doering; Lars Normann; Stephan Diedrich; Frank-Ulrich Weiss; Matthias Evert; Nils Olaf Huebner; Cristin Guenther; Claus Dieter Heidecke; Axel Kramer; René Bussiahn; Klaus-Dieter Weltmann; Onur Pati; Claudia Bender; Wolfram von Bernstorff
Journal:  BMC Cancer       Date:  2012-10-15       Impact factor: 4.430

7.  Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms.

Authors:  Rutger Matthes; Claudia Bender; Rabea Schlüter; Ina Koban; René Bussiahn; Stephan Reuter; Jürgen Lademann; Klaus-Dieter Weltmann; Axel Kramer
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

Review 8.  Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.

Authors:  Sara Rezzola; Alessandra Loda; Michela Corsini; Francesco Semeraro; Tiziana Annese; Marco Presta; Domenico Ribatti
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 9.  Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.

Authors:  Pavol Zubor; Yun Wang; Alena Liskova; Marek Samec; Lenka Koklesova; Zuzana Dankova; Anne Dørum; Karol Kajo; Dana Dvorska; Vincent Lucansky; Bibiana Malicherova; Ivana Kasubova; Jan Bujnak; Milos Mlyncek; Carlos Alberto Dussan; Peter Kubatka; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.